ACADIA Pharmaceuticals Inc.
ACAD
$20.81
$0.090.43%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 273.57M | 71.78M | 26.67M | 18.99M | 143.74M |
| Total Depreciation and Amortization | 2.92M | 2.95M | 2.94M | 2.95M | 5.21M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -237.31M | 12.08M | 12.80M | 9.26M | -138.88M |
| Change in Net Operating Assets | -87.91M | -12.52M | 21.55M | -10.88M | 30.31M |
| Cash from Operations | -48.73M | 74.29M | 63.96M | 20.32M | 40.38M |
| Capital Expenditure | -4.01M | -388.00K | -297.00K | -- | -453.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 146.52M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -51.86M | -78.96M | -43.00M | -124.05M | -23.91M |
| Cash from Investing | -55.87M | -79.35M | -43.29M | -124.05M | 122.15M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 22.67M | 9.42M | 15.96M | 1.84M | 1.97M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 22.67M | 9.42M | 15.96M | 1.84M | 1.97M |
| Foreign Exchange rate Adjustments | 7.00K | 0.00 | 24.00K | -5.00K | -60.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -81.93M | 4.36M | 36.64M | -101.89M | 164.44M |